HR 4400
114th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Drug therapy
Infectious and parasitic diseases
Adding Zika Virus to the FDA Priority Review Voucher Program Act
Introduced: February 1, 2016
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2016
Referred to the Subcommittee on Health.
Feb 1, 2016
Referred to the House Committee on Energy and Commerce.
Feb 1, 2016
Introduced in House
Plain-English summary
Adding Zika Virus to the FDA Priority Review Voucher Program Act
This bill amends the Federal Food, Drug, and Cosmetic Act to add the Zika virus to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2